Gene · 4171
Papers3,775
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,775
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular functions of MCM8 and MCM9 and their associated pathologies. | iScience | 2023 | 37378315 | PubTator, text mining | PubMed |
| Interstitial Deletion of 3q21 in a Kuwaiti Child with Multiple Congenital Anomalies-Expanding the Phenotype. | Genes (Basel) | 2023 | 37372405 | PubTator, text mining | PubMed |
| A novel nomogram based on cell cycle-related genes for predicting overall survival in early-onset colorectal cancer. | BMC Cancer | 2023 | 37370046 | PubTator, text mining | PubMed |
| Dextran-Coated Iron Oxide Nanoparticles Loaded with 5-Fluorouracil for Drug-Delivery Applications. | Nanomaterials (Basel) | 2023 | 37368241 | PubTator, text mining | PubMed |
| Circ_0104700 contributes to acute myeloid leukemia progression by enhancing MCM2 expression through targeting miR-665. | Hematology | 2023 | 37358551 | PubTator, text mining | PubMed |
| Identification of key biomarkers and related immune cell infiltration in cervical cancer tissue based on bioinformatics analysis. | Sci Rep | 2023 | 37344577 | PubTator, text mining | PubMed |
| Large-scale map of RNA binding protein interactomes across the mRNA life-cycle. | bioRxiv | 2023 | 37333282 | PubTator, text mining | PubMed |
| Differential In Vivo Effects on Cancer Models by Recorded Magnetic Signals Derived From a Healing Technique. | Dose Response | 2023 | 37325440 | PubTator, text mining | PubMed |
| Exploring Key Genes with Diagnostic Value for Nonalcoholic Steatohepatitis Based on Bioinformatics Analysis. | ACS Omega | 2023 | 37323410 | PubTator, text mining | PubMed |
| Trophoblast PR-SET7 dysfunction induces viral mimicry response and necroptosis associated with recurrent miscarriage. | Proc Natl Acad Sci U S A | 2023 | 37307441 | PubTator, text mining | PubMed |
| Calcyclin-binding protein contributes to cholangiocarcinoma progression by inhibiting ubiquitination of MCM2. | Oncol Res | 2023 | 37305391 | PubTator, text mining | PubMed |
| A novel prognostic biomarker: GINS3 is correlated with methylation and immune escape in liver hepatocellular carcinoma. | Transl Cancer Res | 2023 | 37304536 | PubTator, text mining | PubMed |
| Impaired histone inheritance promotes tumor progression. | Nat Commun | 2023 | 37301892 | PubTator, text mining | PubMed |
| Biological Response of Human Gingival Fibroblasts to Zinc-Doped Hydroxyapatite Designed for Dental Applications-An In Vitro Study. | Materials (Basel) | 2023 | 37297278 | PubTator, text mining | PubMed |
| Meningioma Grading beyond Histopathology: Relevance of Epigenetic and Genetic Features to Predict Clinical Outcome. | Cancers (Basel) | 2023 | 37296907 | PubTator, text mining | PubMed |
| Analysis of AT7519 as a pro-resolution compound in an acetaminophen-induced mouse model of acute inflammation by UPLC-MS/MS. | J Inflamm (Lond) | 2023 | 37291548 | PubTator, text mining | PubMed |
| The EstroGene Database Reveals Diverse Temporal, Context-Dependent, and Bidirectional Estrogen Receptor Regulomes in Breast Cancer. | Cancer Res | 2023 | 37272757 | PubTator, text mining | PubMed |
| Spatiotemporal transcriptomic atlas reveals the dynamic characteristics and key regulators of planarian regeneration. | Nat Commun | 2023 | 37268637 | PubTator, text mining | PubMed |
A high ratio of linoleic acid (n-6 PUFA) to alpha-linolenic acid (n-3 PUFA) adversely affects early stage of human neuronal differentiation and electrophysiological activity of glutamatergic neurons in vitro. | Front Cell Dev Biol | 2023 | 37255597 | PubTator, text mining | PubMed |
| Neural network and kinetic modelling of human genome replication reveal replication origin locations and strengths. | PLoS Comput Biol | 2023 | 37253070 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4171/papers?page=17